Blind Pose Prediction, Scoring, and Affinity Ranking of the CSAR 2014 Dataset

Journal of Chemical Information and Modeling

Volumn 56, Issue 6, 2016, Pages 996-1003

  Martiny, Virginie Y ^a,b   Martz, François ^a   Selwa, Edithe ^a   Iorga, Bogdan I ^a  

^a INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS;

COAGULATION FACTOR; CONFORMATIONAL SPACE; METHYLTRANSFERASES; PRELIMINARY ANALYSIS; PROTEIN DATA BANK; SCORING FUNCTIONS; SPLEEN TYROSINE KINASE; STRUCTURAL INFORMATION;

PROTEINS;

BLOOD CLOTTING FACTOR 10A; PROTEIN; PROTEIN KINASE SYK; TRANSFER RNA METHYLTRANSFERASE;

BENCHMARKING; CHEMISTRY; METABOLISM; MOLECULAR DOCKING; PROTEIN CONFORMATION; PROTEIN DATABASE;

BENCHMARKING; DATABASES, PROTEIN; FACTOR XA; MOLECULAR DOCKING SIMULATION; PROTEIN CONFORMATION; PROTEINS; SYK KINASE; TRNA METHYLTRANSFERASES;

EID: 84976383871     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/acs.jcim.5b00337     Document Type: Article

References (35)

1. Dunbar, J. B., Jr.; Smith, R. D.; Yang, C. Y.; Ung, P. M.; Lexa, K. W.; Khazanov, N. A.; Stuckey, J. A.; Wang, S.; Carlson, H. A. CSAR Benchmark Exercise of 2010: Selection of the Protein-Ligand Complexes J. Chem. Inf. Model. 2011, 51, 2036-2046 10.1021/ci200082t
2. Smith, R. D.; Dunbar, J. B., Jr.; Ung, P. M.; Esposito, E. X.; Yang, C. Y.; Wang, S.; Carlson, H. A. CSAR Benchmark Exercise of 2010: Combined Evaluation Across All Submitted Scoring Functions J. Chem. Inf. Model. 2011, 51, 2115-2131 10.1021/ci200269q
3. Dunbar, J. B., Jr.; Smith, R. D.; Damm-Ganamet, K. L.; Ahmed, A.; Esposito, E. X.; Delproposto, J.; Chinnaswamy, K.; Kang, Y. N.; Kubish, G.; Gestwicki, J. E.; Stuckey, J. A.; Carlson, H. A. CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys J. Chem. Inf. Model. 2013, 53, 1842-1852 10.1021/ci4000486
4. Damm-Ganamet, K. L.; Smith, R. D.; Dunbar, J. B., Jr.; Stuckey, J. A.; Carlson, H. A. CSAR Benchmark Exercise 2011-2012: Evaluation of Results from Docking and Relative Ranking of Blinded Congeneric Series J. Chem. Inf. Model. 2013, 53, 1853-1870 10.1021/ci400025f
5. Ahrens, I.; Bode, C. New Parenteral Anticoagulants: Focus on Factor Xa and Thrombin Inhibitors Curr. Drug Discovery Technol. 2012, 9, 129-136 10.2174/1570163811209020129
6. Nar, H. The Role of Structural Information in the Discovery of Direct Thrombin and Factor Xa Inhibitors Trends Pharmacol. Sci. 2012, 33, 279-288 10.1016/j.tips.2012.03.004
7. Pinto, D. J.; Qiao, J. X.; Knabb, R. M. The Emergence of Factor Xa Inhibitors for the Treatment of Cardiovascular Diseases: A Patent Review Expert Opin. Ther. Pat. 2012, 22, 645-661 10.1517/13543776.2012.680438
8. Thethi, I.; Lewis, B.; Fareed, J. Oral Factor Xa and Direct Thrombin Inhibitors: A Clinical Perspective J. Burn Care Res. 2012, 33, 453-461 10.1097/BCR.0b013e318248bc4c
9. Yeh, C. H.; Fredenburgh, J. C.; Weitz, J. I. Oral Direct Factor Xa Inhibitors Circ. Res. 2012, 111, 1069-1078 10.1161/CIRCRESAHA.112.276741
10. Bondarenko, M.; Curti, C.; Montana, M.; Rathelot, P.; Vanelle, P. Efficacy and Toxicity of Factor Xa Inhibitors J. Pharm. Pharm. Sci. 2013, 16, 74-88
11. Steinberg, B. A.; Becker, R. C. Structure-Function Relationships of Factor Xa Inhibitors: Implications for the Practicing Clinician J. Thromb. Thrombolysis 2014, 37, 234-241 10.1007/s11239-013-0991-z
12. Esmon, C. T. Targeting Factor Xa and Thrombin: Impact on Coagulation and Beyond Thromb. Haemostasis 2014, 111, 625-633 10.1160/TH13-09-0730
13. Ghosh, D.; Tsokos, G. C. Spleen Tyrosine Kinase: An Src family of Non-Receptor Kinase Has Multiple Functions and Represents a Valuable Therapeutic Target in the Treatment of Autoimmune and Inflammatory Diseases Autoimmunity 2010, 43, 48-55 10.3109/08916930903374717
14. Mocsai, A.; Ruland, J.; Tybulewicz, V. L. The SYK Tyrosine Kinase: A Crucial Player in Diverse Biological Functions Nat. Rev. Immunol. 2010, 10, 387-402 10.1038/nri2765
15. Pamuk, O. N.; Tsokos, G. C. Spleen Tyrosine Kinase Inhibition in the Treatment of Autoimmune, Allergic and Autoinflammatory Diseases Arthritis Res. Ther. 2010, 12, 222 10.1186/ar3198
16. Riccaboni, M.; Bianchi, I.; Petrillo, P. Spleen Tyrosine Kinases: Biology, Therapeutic Targets and Drugs Drug Discovery Today 2010, 15, 517-530 10.1016/j.drudis.2010.05.001
17. Uckun, F. M.; Qazi, S. Spleen Tyrosine Kinase as a Molecular Target for Treatment of Leukemias and Lymphomas Expert Rev. Anticancer Ther. 2010, 10, 1407-1418 10.1586/era.10.112
18. Scott, D. L. Role of Spleen Tyrosine Kinase Inhibitors in the Management of Rheumatoid Arthritis Drugs 2011, 71, 1121-1132 10.2165/11591480-000000000-00000
19. Miller, Y. I.; Choi, S. H.; Wiesner, P.; Bae, Y. S. The SYK side of TLR4: Signalling Mechanisms in Response to LPS and Minimally Oxidized LDL Br. J. Pharmacol. 2012, 167, 990-999 10.1111/j.1476-5381.2012.02097.x
20. Kaur, M.; Singh, M.; Silakari, O. Inhibitors of Switch Kinase 'Spleen Tyrosine Kinase' in Inflammation and Immune-Mediated Disorders: A Review Eur. J. Med. Chem. 2013, 67, 434-446 10.1016/j.ejmech.2013.04.070
21. Nijjar, J. S.; Tindell, A.; McInnes, I. B.; Siebert, S. Inhibition of Spleen Tyrosine Kinase in the Treatment of Rheumatoid Arthritis Rheumatology 2013, 52, 1556-1562 10.1093/rheumatology/ket225
22. Norman, P. Spleen Tyrosine Kinase Inhibitors: A Review of the Patent Literature 2010-2013 Expert Opin. Ther. Pat. 2014, 24, 573-595 10.1517/13543776.2014.890184
23. Geahlen, R. L. Getting Syk: Spleen Tyrosine Kinase as a Therapeutic Target Trends Pharmacol. Sci. 2014, 35, 414-422 10.1016/j.tips.2014.05.007
24. Elkins, P. A.; Watts, J. M.; Zalacain, M.; van Thiel, A.; Vitazka, P. R.; Redlak, M.; Andraos-Selim, C.; Rastinejad, F.; Holmes, W. M. Insights into Catalysis by a Knotted TrmD tRNA Methyltransferase J. Mol. Biol. 2003, 333, 931-949 10.1016/j.jmb.2003.09.011
25. Brule, H.; Elliott, M.; Redlak, M.; Zehner, Z. E.; Holmes, W. M. Isolation and Characterization of the Human tRNA-(N1G37) Methyltransferase (TRM5) and Comparison to the Escherichia coli TrmD Protein Biochemistry 2004, 43, 9243-9255 10.1021/bi049671q
26. Christian, T.; Hou, Y. M. Distinct Determinants of tRNA Recognition by the TrmD and Trm5 Methyl Transferases J. Mol. Biol. 2007, 373, 623-632 10.1016/j.jmb.2007.08.010
27. Lahoud, G.; Goto-Ito, S.; Yoshida, K.; Ito, T.; Yokoyama, S.; Hou, Y. M. Differentiating Analogous tRNA Methyltransferases by Fragments of the Methyl Donor RNA 2011, 17, 1236-1246 10.1261/rna.2706011
28. Hill, P. J.; Abibi, A.; Albert, R.; Andrews, B.; Gagnon, M. M.; Gao, N.; Grebe, T.; Hajec, L. I.; Huang, J.; Livchak, S.; Lahiri, S. D.; McKinney, D. C.; Thresher, J.; Wang, H.; Olivier, N.; Buurman, E. T. Selective Inhibitors of Bacterial t-RNA-(N(1)G37) Methyltransferase (TrmD) That Demonstrate Novel Ordering of the Lid Domain J. Med. Chem. 2013, 56, 7278-7288 10.1021/jm400718n
29. Christian, T.; Gamper, H.; Hou, Y. M. Conservation of Structure and Mechanism by Trm5 Enzymes RNA 2013, 19, 1192-1199 10.1261/rna.039503.113
30. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank Nucleic Acids Res. 2000, 28, 235-242 10.1093/nar/28.1.235
31. Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Improved Protein-Ligand Docking Using GOLD Proteins: Struct., Funct., Genet. 2003, 52, 609-623 10.1002/prot.10465
32. Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. AutoDock4 and AutoDockTools4: Automated Docking With Selective Receptor Flexibility J. Comput. Chem. 2009, 30, 2785-2791 10.1002/jcc.21256
33. Trott, O.; Olson, A. J. AutoDock Vina: Improving the Speed and Accuracy of Docking With a New Scoring Function, Efficient Optimization, and Multithreading J. Comput. Chem. 2010, 31, 455-461 10.1002/jcc.21334
34. Surpateanu, G.; Iorga, B. I. Evaluation of Docking Performance in a Blinded Virtual Screening of Fragment-Like Trypsin Inhibitors J. Comput.-Aided Mol. Des. 2012, 26, 595-601 10.1007/s10822-011-9526-x
35. Colas, C.; Iorga, B. I. Virtual Screening of the SAMPL4 Blinded HIV Integrase Inhibitors Dataset J. Comput.-Aided Mol. Des. 2014, 28, 455-462 10.1007/s10822-014-9707-5